The study, the largest Phase 3 IgAN trial conducted to date, also showed the safety profile of sibeprenlimab was favorable and consistent with previously reported data 1. Specifically, 76.3% of ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.

Patna: State govt on Saturday reconstituted three more commissions — Extremely Backward Commission (EBC), Food Protection Commission and Bihar State Child Labour Commission — to look after the ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

New phase 3 data on Apellis Pharmaceuticals (NASDAQ:APLS) and Sobi's Empaveli (pegcetacoplan) indicated that the treatment led to proteinuria reduction that was sustained for a year.

TuHURA Biosciences advances its phase 3 trial of IFx-2.0 for Merkel cell carcinoma, aiming to enhance immune response alongside pembrolizumab. The FDA has lifted a partial clinical hold related to ...

Methods This 52-week, phase 3, multicentre, double-blind clinical trial (NCT02886728) evaluated once-daily oral filgotinib in 1252 patients with RA randomised 2:1:1:2 to filgotinib 200 mg with MTX ...

Carl Pei on How Nothing and CMF Are Betting Big on India’s Youth, Beyond AI Hype, and Bold Smartphone Market Strategy ...

RENT IT NOW, OWN IT LATER. Your Alternative Pathway To Ownership.

RENT IT NOW, OWN IT LATER. Your Alternative Pathway To Ownership.